This medicine will reduce belly fat, weight will reduce quickly, approved in India, know when it will come

When will the medicine to reduce obesity be launched in India

According to a report by ITG, Eli Lilly CEO David Ricks told Reuters that the company hopes to launch Monjaro in India by 2025. The drug is currently undergoing regulatory review.

What is tirzepatide?

Tirzepatide is a new type of drug that works like two hormones, GLP-1 and GIP. These hormones are produced naturally in the body and help control blood sugar. In India, Tirzepatide will be sold only for the treatment of diabetes, not obesity.

How does Tirzepatide work?

• Tirzepatide triggers the pancreas to make more insulin after a meal. Insulin is a hormone that helps cells absorb glucose, lowering blood sugar levels.
• Tirzepatide reduces the production of a hormone called glucagon. Glucagon tells the liver to make glucose, so reducing it also lowers blood sugar.
• Tirzepatide slows down the movement of food from the stomach to the small intestine. This slows down glucose absorption and prevents a rapid rise in blood sugar after a meal.
• Tirzepatide also works on parts of the brain that control appetite, which may reduce hunger and help with weight loss.

How quickly do you lose weight with tirzepatide?

A study published in JAMA Network (Reference.), researchers found that people using tirzepatide began losing weight within a few weeks. The amount of weight loss may depend on your dose of the drug and how well your body can handle higher doses.

What are the side effects of tirzepatide?

Although tirzepatide can be effective in treating type 2 diabetes, it can also have some side effects. Its common side effects include-

• nausea
• Diarrhea
• loss of appetite
• Vomit
• Constipation
• Indigestion
• stomach pain

Some serious side effects may also occur, such as:

• Inflammation of the pancreas (pancreatitis)
• Low Blood Sugar
• Severe allergies
• Serious stomach problems
• Changes in vision
• Gallbladder problems